253 related articles for article (PubMed ID: 30471680)
1. Neurocognitive effects of cannabis: Lessons learned from human experimental studies.
Colizzi M; Bhattacharyya S
Prog Brain Res; 2018; 242():179-216. PubMed ID: 30471680
[TBL] [Abstract][Full Text] [Related]
2. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
Weinstein A; Livny A; Weizman A
Curr Pharm Des; 2016; 22(42):6366-6379. PubMed ID: 27549374
[TBL] [Abstract][Full Text] [Related]
3. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review.
Batalla A; Crippa JA; Busatto GF; Guimaraes FS; Zuardi AW; Valverde O; Atakan Z; McGuire PK; Bhattacharyya S; Martín-Santos R
Curr Pharm Des; 2014; 20(13):2168-85. PubMed ID: 23829359
[TBL] [Abstract][Full Text] [Related]
5. Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition.
Colizzi M; Bhattacharyya S
Curr Addict Rep; 2017; 4(2):62-74. PubMed ID: 28580227
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis.
Cupo L; Plitman E; Guma E; Chakravarty MM
Transl Psychiatry; 2021 Apr; 11(1):217. PubMed ID: 33850098
[TBL] [Abstract][Full Text] [Related]
7. Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies.
Bhattacharyya S; Atakan Z; Martin-Santos R; Crippa JA; McGuire PK
Curr Pharm Des; 2012; 18(32):5045-54. PubMed ID: 22716136
[TBL] [Abstract][Full Text] [Related]
8. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition.
Colizzi M; Ruggeri M; Bhattacharyya S
Front Psychol; 2020; 11():833. PubMed ID: 32528345
[TBL] [Abstract][Full Text] [Related]
10. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
Krebs MO; Kebir O; Jay TM
Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
[TBL] [Abstract][Full Text] [Related]
11. Cannabis-associated psychosis: Neural substrate and clinical impact.
Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
[TBL] [Abstract][Full Text] [Related]
12. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
Allendorfer JB; Szaflarski JP
Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780
[TBL] [Abstract][Full Text] [Related]
13. Neuromolecular Mechanisms of Cannabis Action.
Adel Y; Alexander SPH
Adv Exp Med Biol; 2021; 1264():15-28. PubMed ID: 33332001
[TBL] [Abstract][Full Text] [Related]
14. The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated.
Kayir H; Ruffolo J; McCunn P; Khokhar JY
Curr Top Behav Neurosci; 2023; 63():437-461. PubMed ID: 36318403
[TBL] [Abstract][Full Text] [Related]
15. Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence.
Colizzi M; McGuire P; Pertwee RG; Bhattacharyya S
Neurosci Biobehav Rev; 2016 May; 64():359-81. PubMed ID: 26987641
[TBL] [Abstract][Full Text] [Related]
16. The neuropsychopharmacology of cannabis: A review of human imaging studies.
Bloomfield MAP; Hindocha C; Green SF; Wall MB; Lees R; Petrilli K; Costello H; Ogunbiyi MO; Bossong MG; Freeman TP
Pharmacol Ther; 2019 Mar; 195():132-161. PubMed ID: 30347211
[TBL] [Abstract][Full Text] [Related]
17. Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date.
Sami MB; Rabiner EA; Bhattacharyya S
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1201-24. PubMed ID: 26068702
[TBL] [Abstract][Full Text] [Related]
18. The effects of cannabis use on salience attribution: a systematic review.
Wijayendran SB; O'Neill A; Bhattacharyya S
Acta Neuropsychiatr; 2018 Feb; 30(1):43-57. PubMed ID: 27866486
[TBL] [Abstract][Full Text] [Related]
19. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
[TBL] [Abstract][Full Text] [Related]
20. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis.
Colizzi M; Weltens N; McGuire P; Lythgoe D; Williams S; Van Oudenhove L; Bhattacharyya S
Mol Psychiatry; 2020 Dec; 25(12):3231-3240. PubMed ID: 30770892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
